Last updated on 4 May 2022
Owner Info
OncXerna Therapeutics, Inc.
300 Fifth Avenue, Suite 6040
Waltham MA 02451, UNITED STATES OF AMERICA
Serial Number
2249951 filed on 16 Jul 2021
Correspondent
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
1100 New York Avenue, N.W.,
Washington DC 20005,
UNITED STATES OF AMERICA
2249951
16 Jul 2021
16 Jul 2031
WORD
9 Apr 2021
US
Status Date | Action Taken |
---|---|
4th May 2022 | International Registration in Australia Protected correspondence sent |
3rd May 2022 | IP Right Registration Published |
3rd May 2022 | Status change to Registered/Protected |
24th Feb 2022 | Application Accepted correspondence sent |
23rd Feb 2022 | IP Right has been Examined |
23rd Feb 2022 | IP Right Acceptance Published |
23rd Feb 2022 | Status change to Accepted |
23rd Feb 2022 | Awaiting examination |
23rd Feb 2022 | Examination expedited |
17th Feb 2022 | IP Right Filed Published |